New HemoSonic Chairman Pleased About New President/CEO
Monday, August 11, 2014
HemoSonics, a medical device company developing a novel point-of-care diagnostic to measure coagulation, named William P. (Bill) Moffitt as the new Chairman of the Board of Managers and appointed Timothy J. Fischer as President and Chief Executive Officer.
Moffitt has 40 years of experience in the medical device and diagnostic industries and has spent the last 25 years developing novel technologies into products and solutions that have helped shape the industry.
“Bill brings a wealth of practical experience in building companies and commercializing revolutionary in vitro diagnostics,” said William F. Walker, Founder and CTO of HemoSonics. “We are thrilled to have him as part of the team.”
Fischer has been a pioneer in the in vitro diagnostics industry in the fields of hematology, oncology and pathology for the past 25 years. He has led the design, development and commercialization of dozens of novel diagnostic products. He holds over 40 patents and has authored numerous publications.
"We are pleased and fortunate to have Tim leading our Company as we turn the corner to commercialization," said Moffitt, "His extensive knowledge of hemostasis and his experience in building high performing product development teams will enable us to fulfill our vision of delivering critical patient information at the point of care.”